0

526445

INDRANIB

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

INDRAYANI BIOTECH LTD. Share Price Today

Investment Returns

Over 1 Month -0.74% Over 3 Months 24.23% Over 6 Months -28.11% Over 1 Year -32.20%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

INDRAYANI BIOTECH LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 82.80
  • P/E Ratio (TTM) 96.45
  • Beta 0.64
  • Book Value / share 13.44
  • Return on equity 2.51%
  • EPS (TTM) 0.11
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.08
info icon alternate text

INDRAYANI BIOTECH LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 5.20
Operating Expense 5.77
Net Profit 0.08
Net Profit Margin (%) 1.53
Earnings Per Share (EPS) 0.01
EBITDA 1.34
Effective Tax Rate (%) 27.27
Particulars SEP 2025 (Values in Cr)
Revenue 5.93
Operating Expense 7.13
Net Profit 0.47
Net Profit Margin (%) 7.92
Earnings Per Share (EPS) 0.10
EBITDA 1.79
Effective Tax Rate (%) 25.39
Particulars JUN 2025 (Values in Cr)
Revenue 6.69
Operating Expense 7.41
Net Profit 0.13
Net Profit Margin (%) 1.94
Earnings Per Share (EPS) 0.03
EBITDA 1.64
Effective Tax Rate (%) 23.52
Particulars MAR 2025 (Values in Cr)
Revenue 9.28
Operating Expense 11.47
Net Profit 0.20
Net Profit Margin (%) 2.15
Earnings Per Share (EPS) 0.25
EBITDA 1.72
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 8.19
Operating Expense 8.70
Net Profit 0.11
Net Profit Margin (%) 1.34
Earnings Per Share (EPS) 0.02
EBITDA 1.98
Effective Tax Rate (%) 28.57
Particulars MAR 2025 (Values in Cr)
Revenue 37.77
Operating Expense 53.87
Net Profit 1.45
Net Profit Margin (%) 3.83
Earnings Per Share (EPS) 0.32
EBITDA 8.99
Effective Tax Rate (%) -123.07
Particulars MAR 2024 (Values in Cr)
Revenue 62.32
Operating Expense 62.94
Net Profit 1.46
Net Profit Margin (%) 2.34
Earnings Per Share (EPS) 0.32
EBITDA 9.29
Effective Tax Rate (%) 51.49
Particulars MAR 2023 (Values in Cr)
Revenue 74.48
Operating Expense 69.54
Net Profit 5.06
Net Profit Margin (%) 6.79
Earnings Per Share (EPS) 1.48
EBITDA 8.79
Effective Tax Rate (%) 0.39
Particulars MAR 2022 (Values in Cr)
Revenue 57.99
Operating Expense 53.98
Net Profit 4.23
Net Profit Margin (%) 7.29
Earnings Per Share (EPS) 1.23
EBITDA 6.45
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 21.01
Operating Expense 28.05
Net Profit -10.89
Net Profit Margin (%) -51.83
Earnings Per Share (EPS) -3.18
EBITDA -8.53
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 15.16
ROE % -8.75
ROCE % 3.15
Total Debt to Total Equity 1.79
EBITDA Margin 7.29
Particulars MAR 2024 (Values in Cr)
Book Value / Share 13.86
ROE % 18.22
ROCE % 13.76
Total Debt to Total Equity 1.49
EBITDA Margin 14.97
Particulars MAR 2023 (Values in Cr)
Book Value / Share 12.94
ROE % 29.31
ROCE % 19.98
Total Debt to Total Equity 1.12
EBITDA Margin 13.07
Particulars MAR 2022 (Values in Cr)
Book Value / Share 7.06
ROE % 16.46
ROCE % 14.34
Total Debt to Total Equity 0.78
EBITDA Margin 11.35
Particulars MAR 2021 (Values in Cr)
Book Value / Share 5.76
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.58
EBITDA Margin -22.19
Particulars MAR 2025 (Values in Cr)
Book Value / Share 11.39
ROE % 2.51
ROCE % 6.69
Total Debt to Total Equity 1.14
EBITDA Margin 24.01
Particulars MAR 2024 (Values in Cr)
Book Value / Share 11.07
ROE % 2.78
ROCE % 7.23
Total Debt to Total Equity 1.00
EBITDA Margin 15.12
Particulars MAR 2023 (Values in Cr)
Book Value / Share 11.79
ROE % 12.48
ROCE % 10.59
Total Debt to Total Equity 0.79
EBITDA Margin 11.90
Particulars MAR 2022 (Values in Cr)
Book Value / Share 7.06
ROE % 15.61
ROCE % 14.18
Total Debt to Total Equity 0.73
EBITDA Margin 11.14
Particulars MAR 2021 (Values in Cr)
Book Value / Share 5.83
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.57
EBITDA Margin -20.94
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.28
Total Assets 267.88
Total Liabilities 267.88
Total Equity 99.91
Share Outstanding 4
Price to Book Ratio 1.25
Return on Assets (%) -2.27
Return on Capital (%) -2.58
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.58
Total Assets 234.00
Total Liabilities 234.00
Total Equity 76.26
Share Outstanding 4
Price to Book Ratio 4.44
Return on Assets (%) 2.72
Return on Capital (%) 3.46
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.03
Total Assets 155.96
Total Liabilities 155.96
Total Equity 48.35
Share Outstanding 3
Price to Book Ratio 4.79
Return on Assets (%) 5.60
Return on Capital (%) 7.86
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.50
Total Assets 51.40
Total Liabilities 51.40
Total Equity 24.56
Share Outstanding 3
Price to Book Ratio 4.32
Return on Assets (%) 8.63
Return on Capital (%) 10.46
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.67
Total Assets 40.05
Total Liabilities 40.05
Total Equity 20.08
Share Outstanding 3
Price to Book Ratio 1.09
Return on Assets (%) -27.99
Return on Capital (%) -31.49
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 130.67
Total Liabilities 130.67
Total Equity 55.33
Share Outstanding 4
Price to Book Ratio 1.25
Return on Assets (%) 1.10
Return on Capital (%) 1.24
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.26
Total Assets 126.00
Total Liabilities 126.00
Total Equity 54.51
Share Outstanding 4
Price to Book Ratio 4.44
Return on Assets (%) 1.15
Return on Capital (%) 1.29
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.61
Total Assets 100.29
Total Liabilities 100.29
Total Equity 51.14
Share Outstanding 3
Price to Book Ratio 4.79
Return on Assets (%) 5.04
Return on Capital (%) 5.85
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.44
Total Assets 49.43
Total Liabilities 49.43
Total Equity 24.17
Share Outstanding 3
Price to Book Ratio 4.32
Return on Assets (%) 8.54
Return on Capital (%) 10.33
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.62
Total Assets 39.84
Total Liabilities 39.84
Total Equity 19.95
Share Outstanding 3
Price to Book Ratio 1.09
Return on Assets (%) -27.32
Return on Capital (%) -30.77
Particulars MAR 2025 (Values in Cr)
Net Income -6.10
Cash from Operations -7.90
Cash from Investing 24.74
Cash from Financing -18.29
Net change in Cash -0.29
Free Cash Flow -6.53
Particulars MAR 2024 (Values in Cr)
Net Income 10.42
Cash from Operations -30.35
Cash from Investing -16.33
Cash from Financing 44.23
Net change in Cash -2.45
Free Cash Flow -13.86
Particulars MAR 2023 (Values in Cr)
Net Income 11.93
Cash from Operations 16.18
Cash from Investing -47.39
Cash from Financing 32.73
Net change in Cash 1.53
Free Cash Flow 37.71
Particulars MAR 2022 (Values in Cr)
Net Income 4.43
Cash from Operations 4.11
Cash from Investing -0.55
Cash from Financing -2.72
Net change in Cash 0.82
Free Cash Flow 5.30
Particulars MAR 2021 (Values in Cr)
Net Income -11.21
Cash from Operations 0.25
Cash from Investing -0.70
Cash from Financing -0.27
Net change in Cash -0.72
Free Cash Flow 0.95
Particulars MAR 2025 (Values in Cr)
Net Income 0.64
Cash from Operations 17.35
Cash from Investing -1.33
Cash from Financing -16.21
Net change in Cash -0.20
Free Cash Flow 18.20
Particulars MAR 2024 (Values in Cr)
Net Income 3.00
Cash from Operations 26.08
Cash from Investing -7.25
Cash from Financing -19.18
Net change in Cash -0.35
Free Cash Flow 32.43
Particulars MAR 2023 (Values in Cr)
Net Income 5.05
Cash from Operations 8.33
Cash from Investing -14.09
Cash from Financing 4.93
Net change in Cash -0.82
Free Cash Flow 10.23
Particulars MAR 2022 (Values in Cr)
Net Income 4.22
Cash from Operations 3.46
Cash from Investing 0.58
Cash from Financing -3.23
Net change in Cash 0.81
Free Cash Flow 3.52
Particulars MAR 2021 (Values in Cr)
Net Income -10.88
Cash from Operations 0.51
Cash from Investing -0.56
Cash from Financing -0.73
Net change in Cash -0.77
Free Cash Flow 0.90
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
GOCL CORPORATION LIMITED 436.45 8.04 0.68 2163.59 223.60 449.40
MAFATLAL INDUSTRIES LTD. 131.65 10.25 1.23 950.24 107.15 204.90
MAJESTIC AUTO LTD. 340.25 15.88 0.52 353.86 276.00 464.90
ANDREW YULE & COMPANY LTD. 26.57 0.00 3.99 1299.14 15.50 32.30
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
GOCL CORPORATION LIMITED 436.45 12.04 0.99 2163.59 223.60 449.40
MAFATLAL INDUSTRIES LTD. 131.65 10.13 1.22 950.24 107.15 204.90
OSWAL GREENTECH LIMITED 23.90 17.19 0.25 613.77 19.70 49.44
EMPIRE INDUSTRIES LTD. 1018.40 11.78 1.73 611.04 811.05 1260.00

INDRAYANI BIOTECH LTD. shareholding pattern

Holding
63.61%
33.25%
3.13%
24.56%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

INDRAYANI BIOTECH LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
10.61 -3.54 redarrow
red-green-graph indicator
15 Bearish
1 Bullish
  • 5 Days 10.90
  • 26 Days 11.10
  • 10 Days 11.00
  • 50 Days 11.00
  • 12 Days 11.00
  • 100 Days 11.20
  • 20 Days 11.10
  • 200 Days 13.50
11.06 PIVOT
First Support 10.85 First Resistance 11.20 Second Support 10.71 Second Resistance 11.41 Third Support 10.50 Third Resistance 11.55
RSI 41.70 ADX 20.84 MACD -0.03 Williams % R -96.74 Commodity Channel Index (CCI) -34.17
Date 2026-06-19 Week 56639.00 Same Day 51916.00 Month 108216.00
1 Year 0.65 3 Year 0.49
Over 1 Month
-0.74% down
Over 1 Year
-32.20% down
Over 3 Months
24.23% down
Over 3 Years
-44.59% down
Over 6 Months
-28.11% down
Over 5 Years
-1.23% down

INDRAYANI BIOTECH LTD. Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Indrayani Biotech Ltd?

Answer Field

Indrayani Biotech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 10.61 as on Jun 19 2026 03:29 PM.

What is the Market Cap of Indrayani Biotech Ltd Share?

Answer Field

The market cap of Indrayani Biotech Ltd for NSE ₹ 0.00 & for BSE ₹ 82.80 as on Jun 19 2026 03:29 PM.

What is the 52 Week High and Low of Indrayani Biotech Ltd?

Answer Field

The 52 Week High and Low of Indrayani Biotech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 18.08 and ₹ 6.69.

What is 1 year return for Indrayani Biotech Ltd?

Answer Field

The 1 year returns on the stock has been -32.20%.

What is the P/E Ratio of Indrayani Biotech Ltd Share?

Answer Field

As on Jun 19 2026 03:29 PM the price-to-earnings (PE) ratio for Indrayani Biotech Ltd share is 96.45.

What is the PB ratio of Indrayani Biotech Ltd Share?

Answer Field

As on Jun 19 2026 03:29 PM, the price-to-book (PB) ratio for Indrayani Biotech Ltd share is 13.44.

How to Buy Indrayani Biotech Ltd Share?

Answer Field

You can trade in Indrayani Biotech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Indrayani Biotech Ltd Share on Bajaj Broking App?

Answer Field

To buy Indrayani Biotech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Indrayani Biotech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|